Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
151.57
-0.01 (-0.01%)
Nov 28, 2025, 11:04 AM EST - Market open
Neurocrine Biosciences Analyst Ratings
Total Analysts
18
Consensus Rating
Strong Buy
Price Target
$172.33
Upside
+13.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $178 → $173 | Buy | Maintains | $178 → $173 | +14.14% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $171 → $179 | Buy | Maintains | $171 → $179 | +18.10% | Nov 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $165 → $172 | Strong Buy | Reiterates | $165 → $172 | +13.48% | Oct 30, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $160 → $164 | Strong Buy | Maintains | $160 → $164 | +8.20% | Oct 29, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $175 → $203 | Strong Buy | Maintains | $175 → $203 | +33.93% | Oct 29, 2025 |
| Stifel | Stifel | Strong Buy Maintains $174 → $183 | Strong Buy | Maintains | $174 → $183 | +20.74% | Oct 29, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $156 → $160 | Buy | Maintains | $156 → $160 | +5.56% | Oct 29, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $175 → $179 | Buy | Maintains | $175 → $179 | +18.10% | Oct 29, 2025 |
| Needham | Needham | Strong Buy Maintains $170 → $184 | Strong Buy | Maintains | $170 → $184 | +21.40% | Oct 29, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $175 | Strong Buy | Initiates | $175 | +15.46% | Oct 21, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $163 → $168 | Buy | Maintains | $163 → $168 | +10.84% | Oct 20, 2025 |
| UBS | UBS | Strong Buy Maintains $188 → $195 | Strong Buy | Maintains | $188 → $195 | +28.65% | Oct 9, 2025 |
| Needham | Needham | Strong Buy Maintains $161 → $170 | Strong Buy | Maintains | $161 → $170 | +12.16% | Sep 22, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $144 → $149 | Buy | Maintains | $144 → $149 | -1.70% | Sep 5, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $158 → $163 | Buy | Maintains | $158 → $163 | +7.54% | Sep 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $183 → $171 | Buy | Maintains | $183 → $171 | +12.82% | Aug 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.